Breaking News
Get 45% Off 0
💰 Hidden Value: These stocks are trading at deep discounts to true worth
Get the list

Clearpoint Neuro stock target raised to $9 on growth momentum

Published Mar 13, 2024 10:02
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
CLPT
-1.76%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

On Wednesday, Stifel demonstrated confidence in Clearpoint Neuro Inc. (NASDAQ:CLPT) by increasing the stock's price target to $9.00, up from the previous $8.00, while reaffirming a Buy rating. This adjustment reflects the company's strong performance, which includes a 17% growth in top-line revenue and a significant reduction in cash burn for the year 2023.

Clearpoint Neuro has shown a promising start to 2024, achieving key product approvals, a record number of system installations, and receiving support from clinical publications. The company's efforts in Functional Neurosurgery have begun to pay off, with new product launches signaling the realization of its pipeline efforts cultivated over recent years.

The company has notably placed at least six systems in the early months of 2024, a substantial increase from the previous annual rate of six systems. This surge is anticipated to generate consistent "razor blade" revenue over a more extended period. The growth in system placements is a positive indicator of the company's future revenue streams.

On the Biologics front, Clearpoint Neuro is expanding its partnership base and enhancing its service offerings. These developments are expected to drive a minimum of 20% revenue growth in 2024. The company is strategically positioning itself for high, sustainable growth and improved profitability.

Stifel's outlook for Clearpoint Neuro remains optimistic. The firm anticipates that while quarterly results may still show variability, the overall trajectory for the company is increasingly compelling. This is due in part to the expected continued growth and the lowering of regulatory risks associated with the company's operations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Clearpoint Neuro stock target raised to $9 on growth momentum
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email